Pathstone Holdings’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.17M Buy
10,644
+478
+5% +$68.1K ﹤0.01% 1329
2025
Q4
$1.69M Sell
10,166
-413
-4% -$69.1K 0.01% 1123
2025
Q3
$2.07M Sell
10,579
-3,239
-23% -$533K 0.01% 1008
2025
Q2
$1.25M Buy
+13,818
New +$1.09M ﹤0.01% 1277
2025
Q1
Sell
-3,282
Closed -$435K 2398
2024
Q4
$435K Buy
+3,282
New +$308K ﹤0.01% 1787

Other funds holding ALAB

Pathstone Holdings's ALAB Position: Q1 2026 in Review

Pathstone Holdings increased its Astera Labs (ALAB) stake by 4.7% in Q1 2026, buying an estimated $68.1K and bringing the position to 10,644 shares worth $1.17M. The position accounts for ﹤0.01% of the portfolio, ranked #1329.

Pathstone Holdings first reported a position in ALAB in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.07M in Q3 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Pathstone Holdings held 10,644 shares of Astera Labs worth $1.17M as of Q1 2026.
  • Pathstone Holdings bought 478 Astera Labs shares in Q1 2026, an estimated $68.1K.
  • Astera Labs made up ﹤0.01% of Pathstone Holdings's portfolio in Q1 2026, its #1329 holding.
  • Pathstone Holdings first reported a position in Astera Labs in Q4 2024 and has held it in 5 quarters since.
  • Pathstone Holdings's Astera Labs position peaked at $2.07M in Q3 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.